Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer.

Elgogary A, Xu Q, Poore B, Alt J, Zimmermann SC, Zhao L, Fu J, Chen B, Xia S, Liu Y, Neisser M, Nguyen C, Lee R, Park JK, Reyes J, Hartung T, Rojas C, Rais R, Tsukamoto T, Semenza GL, Hanes J, Slusher BS, Le A.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):E5328-36. doi: 10.1073/pnas.1611406113. Epub 2016 Aug 24.

2.

3D Imaging of Nanoparticle Distribution in Biological Tissue by Laser-Induced Breakdown Spectroscopy.

Gimenez Y, Busser B, Trichard F, Kulesza A, Laurent JM, Zaun V, Lux F, Benoit JM, Panczer G, Dugourd P, Tillement O, Pelascini F, Sancey L, Motto-Ros V.

Sci Rep. 2016 Jul 20;6:29936. doi: 10.1038/srep29936.

3.

Rescue of mitochondrial function in parkin-mutant fibroblasts using drug loaded PMPC-PDPA polymersomes and tubular polymersomes.

Yealland G, Battaglia G, Bandmann O, Mortiboys H.

Neurosci Lett. 2016 Sep 6;630:23-9. doi: 10.1016/j.neulet.2016.06.065. Epub 2016 Jul 10.

4.

Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.

Obaid G, Broekgaarden M, Bulin AL, Huang HC, Kuriakose J, Liu J, Hasan T.

Nanoscale. 2016 Jul 7;8(25):12471-503. doi: 10.1039/c5nr08691d. Epub 2016 Jun 20.

PMID:
27328309
5.

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

Pérez-Medina C, Abdel-Atti D, Tang J, Zhao Y, Fayad ZA, Lewis JS, Mulder WJ, Reiner T.

Nat Commun. 2016 Jun 20;7:11838. doi: 10.1038/ncomms11838.

6.

Solid Tumor Therapy Using a Cannon and Pawn Combination Strategy.

Song W, Tang Z, Zhang D, Wen X, Lv S, Liu Z, Deng M, Chen X.

Theranostics. 2016 Apr 28;6(7):1023-30. doi: 10.7150/thno.14741. eCollection 2016.

7.

Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

Luk BT, Fang RH, Hu CM, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L.

Theranostics. 2016 Apr 28;6(7):1004-11. doi: 10.7150/thno.14471. eCollection 2016.

8.

Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.

Antoine TE, Hadigal SR, Yakoub AM, Mishra YK, Bhattacharya P, Haddad C, Valyi-Nagy T, Adelung R, Prabhakar BS, Shukla D.

J Immunol. 2016 Jun 1;196(11):4566-75. doi: 10.4049/jimmunol.1502373. Epub 2016 Apr 27.

PMID:
27183601
9.

Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles.

Xue Y, Xu X, Zhang XQ, Farokhzad OC, Langer R.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5552-7. doi: 10.1073/pnas.1603840113. Epub 2016 May 2.

PMID:
27140638
10.

Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.

Adjei IM, Sharma B, Peetla C, Labhasetwar V.

J Control Release. 2016 Jun 28;232:83-92. doi: 10.1016/j.jconrel.2016.04.019. Epub 2016 Apr 15.

PMID:
27090164
11.

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ.

Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221.

12.

In vivo imaging of prostate cancer using an anti-PSMA scFv fragment as a probe.

Mazzocco C, Fracasso G, Germain-Genevois C, Dugot-Senant N, Figini M, Colombatti M, Grenier N, Couillaud F.

Sci Rep. 2016 Mar 21;6:23314. doi: 10.1038/srep23314.

13.

Nanomedicines for Endothelial Disorders.

Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R.

Nano Today. 2015 Dec 1;10(6):759-776.

PMID:
26955397
14.

Paclitaxel-Loaded Polymersomes for Enhanced Intraperitoneal Chemotherapy.

Simón-Gracia L, Hunt H, Scodeller PD, Gaitzsch J, Braun GB, Willmore AM, Ruoslahti E, Battaglia G, Teesalu T.

Mol Cancer Ther. 2016 Apr;15(4):670-9. doi: 10.1158/1535-7163.MCT-15-0713-T. Epub 2016 Feb 15.

PMID:
26880267
15.

Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.

Hong E, Usiskin IM, Bergamaschi C, Hanlon DJ, Edelson RL, Justesen S, Pavlakis GN, Flavell RA, Fahmy TM.

J Biol Chem. 2016 Apr 22;291(17):8931-50. doi: 10.1074/jbc.M115.695304. Epub 2015 Dec 30.

PMID:
26719339
16.

Biomaterials and emerging anticancer therapeutics: engineering the microenvironment.

Gu L, Mooney DJ.

Nat Rev Cancer. 2016 Jan;16(1):56-66. doi: 10.1038/nrc.2015.3.

17.

Anticancer activity of bicalutamide-loaded PLGA nanoparticles in prostate cancers.

Guo J, Wu SH, Ren WG, Wang XL, Yang AQ.

Exp Ther Med. 2015 Dec;10(6):2305-2310. Epub 2015 Oct 14.

18.

Polysaccharide-based nanoparticles for theranostic nanomedicine.

Swierczewska M, Han HS, Kim K, Park JH, Lee S.

Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):70-84. doi: 10.1016/j.addr.2015.11.015. Epub 2015 Nov 27. Review.

PMID:
26639578
19.

Nanodiamonds: The intersection of nanotechnology, drug development, and personalized medicine.

Ho D, Wang CH, Chow EK.

Sci Adv. 2015 Aug 21;1(7):e1500439. doi: 10.1126/sciadv.1500439. eCollection 2015 Aug. Review.

20.

Smart nanosystems: Bio-inspired technologies that interact with the host environment.

Kwon EJ, Lo JH, Bhatia SN.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14460-6. doi: 10.1073/pnas.1508522112. Epub 2015 Nov 23. Review.

Items per page

Supplemental Content

Write to the Help Desk